Current treatment status-Undergoing active treatment-Progressive despite several lines of treatment - Page 8 of 24 Posts on Medivizor
Navigation Menu

Current treatment status-Undergoing active treatment-Progressive despite several lines of treatment Posts on Medivizor

Zanubrutinib treatment for relapsed or unresponsive small lymphocytic lymphoma

Zanubrutinib treatment for relapsed or unresponsive small lymphocytic lymphoma

Posted by on May 31, 2020 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study aimed to investigate the safety and effectiveness of zanubrutinib in patients with relapsed/unresponsive chronic lymphocytic leukemia and small lymphocytic lymphoma. This study concluded that zanubrutinib was well tolerated and with promising effectiveness in these patients.    Some background Bruton tyrosine...

Read More

How safe and effective is targeted therapy abemaciclib for patients with relapsed or refractory mantle cell lymphoma?

How safe and effective is targeted therapy abemaciclib for patients with relapsed or refractory mantle cell lymphoma?

Posted by on May 24, 2020 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study examined the safety and effectiveness of targeted therapy abemaciclib (Verzenio) for patients with relapsed or refractory mantle cell lymphoma (MCL). The results showed that abemaciclib had promising effectiveness and was relatively safe in these patients. Some background MCL is an aggressive type of lymphoma. During...

Read More

The benefits of repeated cytoreductive surgery and hyperthermic peritoneal chemotherapy in advanced colorectal cancer

The benefits of repeated cytoreductive surgery and hyperthermic peritoneal chemotherapy in advanced colorectal cancer

Posted by on May 21, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated the benefits of repeated cytoreductive surgery (CRS) and hyperthermic peritoneal chemotherapy (HIPEC) in patients with advanced colorectal cancer. Researchers suggested that repeated treatment improves the survival of patients with advanced colorectal cancer, without an increase in side effects. Some background...

Read More

Which low-intensity chemotherapy is most effective for patients with classical Hodgkin lymphoma receiving stem cell transplantation?

Which low-intensity chemotherapy is most effective for patients with classical Hodgkin lymphoma receiving stem cell transplantation?

Posted by on May 10, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study compared the effectiveness of three low-intensity chemotherapy combinations to treat patients with classical Hodgkin lymphoma (HL) following stem cell transplantation (SCT). There were no significant differences between the three chemotherapy types in terms of patients’ survival and relapse. Some background...

Read More

Tucatinib in combination with trastuzumab and capecitabine for HER2 positive metastatic breast cancer

Tucatinib in combination with trastuzumab and capecitabine for HER2 positive metastatic breast cancer

Posted by on May 6, 2020 in Breast cancer | 0 comments

In a nutshell This study aimed to investigate the safety and effectiveness of tucatinib in combination with trastuzumab and capecitabine in patients with HER2 positive metastatic breast cancer who have had disease progression with other treatments.   This study concluded that this treatment combination was safe and...

Read More

Have the outcomes of stem cell transplants for young patients with relapsed or refractory Hodgkin lymphoma improved over time?

Have the outcomes of stem cell transplants for young patients with relapsed or refractory Hodgkin lymphoma improved over time?

Posted by on Apr 25, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study examined if the outcomes of stem cell transplants (SCT) have improved for young patients with relapsed or refractory Hodgkin lymphoma (HL) over time. The results showed that SCT has improved the survival rate and reduced the relapse rate of HL in young patients in recent years. Some background While initial treatment is...

Read More

How effective and safe is high-dose chemotherapy and stem cell transplant for children with lymphoma?

How effective and safe is high-dose chemotherapy and stem cell transplant for children with lymphoma?

Posted by on Apr 14, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study examined the effectiveness and safety of high-dose chemotherapy and stem cell transplants for children with lymphoma. The study showed that the combination treatment was very effective but that the dose may need to be adjusted for some patients. Some background Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL)...

Read More

Do biological drugs work better alone or in combination with other drugs for patients with advanced non-small cell lung cancer who previously received treatment?

Posted by on Apr 7, 2020 in Lung cancer | 0 comments

In a nutshell This study compared if anti-PD-1 biological drugs were more effective alone or when used with other drugs to treat patients with advanced non-small cell lung cancer who had previously received treatment. The results showed that the combination of anti-PD-1 and other drugs such as chemotherapy improved patients’ survival more than...

Read More

Evaluating brentuximab vedotin plus bendamustine for patients with hard-to-treat classical Hodgkin lymphoma

Evaluating brentuximab vedotin plus bendamustine for patients with hard-to-treat classical Hodgkin lymphoma

Posted by on Mar 8, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study evaluated the effectiveness of brentuximab vedotin (Adcetris) plus bendamustine (Treanda) for patients with hard to treat classical Hodgkin lymphoma (cHL). This study found that this regimen is an effective salvage therapy for these patients. Some background Standard first-line chemotherapy is highly effective in treating...

Read More

The comparison of outcomes of two salvage therapies in patients with relapsed or unresponsive acute myeloid leukemia

Posted by on Mar 4, 2020 in Leukemia | 0 comments

In a nutshell The study evaluated the effectiveness of two salvage therapies – mitoxantrone (Novantrone), etoposide (Etopophos), and cytarabine (Cytosar-U) also known as MEC and cladribine (Leustatin), cytarabine, filgrastim (Neupogen), and mitoxantrone also known as CLAG-M, for treating relapsed/refractory acute myeloid leukemia...

Read More

Venetoclax in elderly patients with relapsed or unresponsive chronic lymphocytic leukemia

Posted by on Feb 25, 2020 in Leukemia | 0 comments

In a nutshell This study aimed to investigate if venetoclax was safe and effective in older patients with relapsed/refractory chronic lymphocytic leukemia outside of clinical trials. This study concluded that venetoclax is safe and effective in these patients. Some background Chronic lymphocytic leukemia (CLL) is commonly diagnosed in older people....

Read More